Zobrazeno 1 - 10
of 44
pro vyhledávání: '"Kathrine R. Tan"'
Autor:
Olivier Briet, Hannah Koenker, Laura Norris, Ryan Wiegand, Jodi Vanden Eng, Alex Thackeray, John Williamson, John E. Gimnig, Filomeno Fortes, Martin Akogbeto, Anges W. Yadouleton, Maurice Ombok, M. Nabie Bayoh, Themba Mzilahowa, Ana Paula Abílio, Samuel Mabunda, Nelson Cuamba, Elhadji Diouf, Lassana Konaté, Busiku Hamainza, Cecilia Katebe-Sakala, Gabriel Ponce de León, Kwame Asamoa, Adam Wolkon, Stephen C. Smith, Isabel Swamidoss, Mike Green, Salam Gueye, Jules Mihigo, Juliette Morgan, Ellen Dotson, Allen S. Craig, Kathrine R. Tan, Robert A. Wirtz, Tom Smith
Publikováno v:
Malaria Journal, Vol 19, Iss 1, Pp 1-15 (2020)
Abstract Background Long-lasting insecticidal nets (LLINs) are the primary malaria prevention and control intervention in many parts of sub-Saharan Africa. While LLINs are expected to last at least 3 years under normal use conditions, they can lose e
Externí odkaz:
https://doaj.org/article/1c45186a74084aeea5fe36db4ff2c2c2
Publikováno v:
Malaria Journal, Vol 17, Iss 1, Pp 1-4 (2018)
Abstract Background Malaria chemoprophylaxis options in pregnancy are limited, and atovaquone–proguanil (AP) is not recommended because of insufficient safety evidence. An anonymous, internet-based survey was disseminated to describe outcomes of pr
Externí odkaz:
https://doaj.org/article/015c150366bb4a128418116f3f2f1b63
Autor:
Jennifer L, Kriss, Peter M, Boersma, Emalee, Martin, Kirsten, Reed, Jennifer, Adjemian, Nathaniel, Smith, Rosalind J, Carter, Kathrine R, Tan, Arunkumar, Srinivasan, Sunanda, McGarvey, Jennifer, McGehee, Danielle, Henderson, Noah, Aleshire, Adi V, Gundlapalli
Publikováno v:
MMWR. Morbidity and Mortality Weekly Report. 71:1374-1378
Vaccination with JYNNEOS vaccine (Modified Vaccinia Ankara vaccine, Bavarian Nordic) to prevent monkeypox commenced shortly after confirmation of the first monkeypox case in the current outbreak in the United States on May 17, 2022 (1). To date, more
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::d286e73fd031039e266b1548004129f4
https://doi.org/10.15585/mmwr.mm7143e2
https://doi.org/10.15585/mmwr.mm7143e2
Publikováno v:
Clinical Infectious Diseases. 76:1161-1163
Return to international travel in the COVID-19 pandemic recovery period is expected to increase the number of patients with imported malaria in the United States (US). Malaria prevention in travelers and preparedness for timely diagnosis and appropri
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::17717e18a695632224f18edffd906d98
https://doi.org/10.1093/cid/ciad061
https://doi.org/10.1093/cid/ciad061
Publikováno v:
Morbidity and mortality weekly report. Surveillance summaries (Washington, D.C. : 2002). 71(8)
Malaria in humans is caused by intraerythrocytic protozoa of the genus Plasmodium. These parasites are transmitted by the bite of an infective female Anopheles species mosquito. Most malaria infections in the United States and its territories occur a
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5be56066fb4f091fb2188fa4cbac22c7
https://pubmed.ncbi.nlm.nih.gov/36048717
https://pubmed.ncbi.nlm.nih.gov/36048717
Publikováno v:
Clinical Infectious Diseases. 73:1965-1972
Background Severe malaria can be deadly and requires treatment with intravenous artesunate (IVAS). The Centers for Disease Control and Prevention provided IVAS starting 1 April 2019 for all patients with severe malaria in the United States. This stud
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::60c0e6f456b3115d252eb744dfd24065
https://doi.org/10.1093/cid/ciab570
https://doi.org/10.1093/cid/ciab570
Publikováno v:
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
Background Studies have demonstrated the safety and efficacy of intravenous artesunate (IVAS) for treatment of severe malaria in endemic and nonendemic countries. However, post-artesunate delayed hemolysis (PADH) is an increasingly recognized phenome
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8ee2660c28fce76225bcef398d541e38
https://pubmed.ncbi.nlm.nih.gov/36052468
https://pubmed.ncbi.nlm.nih.gov/36052468
Autor:
Sallyann M Coleman King, Michelle S. Chevalier, Deborah Dowell, Catherine A. McLean, Titilope Oduyebo, Katherine R. Shealy, Tonya R Williams, Anna A. Minta, Angela M. Thompson-Paul, Ugonna C Ijeoma, Miriam Shiferaw, Kathrine R. Tan, Elfriede Agyemang, John K. Iskander, Hanna B. Demeke, Allan W. Taylor, Sara E. Oliver, Daniel Wozniczka, Maleeka Glover
Publikováno v:
International Journal of Environmental Research and Public Health, Vol 18, Iss 7251, p 7251 (2021)
International Journal of Environmental Research and Public Health
Volume 18
Issue 14
International Journal of Environmental Research and Public Health
Volume 18
Issue 14
Context: In response to the COVID-19 pandemic, the Centers for Disease Prevention and Control (CDC) clinicians provided real-time telephone consultation to healthcare providers, public health practitioners, and health department personnel. Objective:
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9085425edbe837b218b444f6b41e60f8
https://www.mdpi.com/1660-4601/18/14/7251
https://www.mdpi.com/1660-4601/18/14/7251
Publikováno v:
Morbidity and Mortality Weekly Report
An estimated 219 million cases of malaria occurred worldwide in 2017, causing approximately 435,000 deaths (1). Malaria is caused by intraerythrocytic protozoa of the genus Plasmodium transmitted to humans through the bite of an infective Anopheles m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::433b5bd7efb0ead663ecf769e3b59a20
https://doi.org/10.15585/mmwr.mm6846a4
https://doi.org/10.15585/mmwr.mm6846a4
Autor:
Stephanie D. Kovacs, Emily Bartlett, Kristin L. Andrejko, Julie Gutman, Emma Slutsker, Kathrine R. Tan, Romana Mayer
Publikováno v:
Travel Med Infect Dis
Background Malaria infection poses a significant risk in pregnancy, yet chemoprophylaxis for pregnant women is limited. A systematic review was conducted to evaluate the incidence of adverse outcomes after atovaquone-proguanil (AP) exposure during pr
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::79f6c2ddd2c2b0fd46fef6e9e9f7526e
https://doi.org/10.1016/j.tmaid.2019.01.008
https://doi.org/10.1016/j.tmaid.2019.01.008